Literature DB >> 11369060

Modified order of allelic replication in lymphoma patients at different disease stages.

A Amiel1, A Elis, D Blumenthal, E Gaber, M D Fejgin, R Dubinsky, M Lishner.   

Abstract

Asynchronous replication of homologous loci was reported in lymphocytes of patients with lymphoma, ovarian and renal cancer as well as in lymphocytes of patients with premalignant conditions, for example, essential mixed cryoglobulinemia associated with hepatitis C virus and in monoclonal gammopathy of unknown significance. In the present study we evaluated the replication pattern in lymphocytes of four groups of patients with intermediate grade of non-Hodgkin lymphoma at various stages of their disease: 1) at diagnosis; 2) during cytotoxic treatment; 3) in remission; and 4) in relapse. A significantly higher proportion of the asynchronous pattern of replication at diagnosis, during cytotoxic treatment, and in relapse was noted as compared to healthy controls and to patients who achieved remission of their lymphoma. Also, the frequency of the two doublets (DD) pattern in every group studied was significantly lower than in the controls. If our findings can be confirmed in larger, long-term prospective studies, it may allow the use of a simple and inexpensive tool to closely observe patients with lymphoma who are at high risk for relapse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369060     DOI: 10.1016/s0165-4608(00)00381-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Genome-wide copy number profiling of single cells in S-phase reveals DNA-replication domains.

Authors:  Niels Van der Aa; Jiqiu Cheng; Ligia Mateiu; Masoud Zamani Esteki; Parveen Kumar; Eftychia Dimitriadou; Evelyne Vanneste; Yves Moreau; Joris Robert Vermeesch; Thierry Voet
Journal:  Nucleic Acids Res       Date:  2013-01-07       Impact factor: 16.971

2.  Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels.

Authors:  Samuel Cytron; Evgeni Stepnov; Igor Bounkin; Maya Mashevich; Aviva Dotan; Lydia Avivi
Journal:  Clin Epigenetics       Date:  2011-03-29       Impact factor: 6.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.